Fighting the monster

Nature

Volumn 466, Issue 7304 SUPPL., 2010, Pages

  Maxmen, Amy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; EFAVIRENZ; NEVIRAPINE; PROTEINASE INHIBITOR; RIFAMPICIN; TUBERCULOSTATIC AGENT;

DISEASE PREVALENCE; DISEASE TREATMENT; HEALTH IMPACT; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE SYSTEM; INFECTIOUS DISEASE; POLICY MAKING; TUBERCULOSIS;

ALLERGIC REACTION; ARTHRALGIA; COMORBIDITY; DRUG ANTAGONISM; FATALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; NAUSEA; PNEUMONIA; PRIORITY JOURNAL; SHORT SURVEY; SUPERINFECTION; TUBERCULOSIS; WEIGHT REDUCTION;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; CLINICAL TRIALS AS TOPIC; COMORBIDITY; DISEASE PROGRESSION; DRUG INTERACTIONS; DRUG RESISTANCE, MICROBIAL; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFANT; PREGNANCY; TUBERCULOSIS;

TANZANIA;

EID: 77954753869     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature09243     Document Type: Short Survey

References (7)

1. Braitstein, P. et al. Lancet 367, 817-824 (2006).
2. Lawn, S. D., Harries, A. D. & Wood, R. Curr. Opin. HIV AIDS 5, 18-26 (2010).
3. Meintjes, G. et al. Lancet Infect. Dis. 8, 516-523 (2008).
4. Karim, S. A. et al. N. Engl. J. Med. 362, 697-706 (2010).
5. Wilson, D. & Meintjes, G. N. Engl. J. Med. 362, 2137 (2010).
6. Garcia-Vidal, C., Salvado, M. & Salavert, N. Engl. J. Med. 362, 2137-2138 (2010).
7. Kadhiravan, T. N. Engl. J. Med. 362, 2138 (2010).